Vista Current Coverage

All Johnson & Johnson Articles

J&J Faces Antitrust Probe By FTC For Its Rheumatoid Arthritis Drug

 Reportedly, in June The Federal Trade Commission (FTC) issued civil subpoenas to Johnson and Johnson to investigate whether contracting practices for Remicade, its popular rheumatoid arthritis drug, violates antitrust laws.  J&J confirmed the investigation by the FTC and informed that a “civil investigative demand,” or...

J&J Continuing Research For Mid-Stage HIV Vaccine

As per reports, Johnson & Johnson (JNJ) is staged to move forward with a late-stage study of an investigational vaccine for Human Immunodeficiency Virus (HIV), a condition that weakens the immune system of the body in countries like America and Europe. The company is continuing its...

J&J Accelerates Quarterly Profits

Recently, Johnson & Johnson (JNJ) announced that their Q1 earnings which exceeded market expectations. The company highlighted how their drug Stelara, used for the treatment of psoriasis and Crohn’s disease, enjoyed a double-digit increase of about 32% bringing it to  $1.41 billion & now is...